<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04399122</url>
  </required_header>
  <id_info>
    <org_study_id>FWH20160007H</org_study_id>
    <nct_id>NCT04399122</nct_id>
  </id_info>
  <brief_title>Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone</brief_title>
  <official_title>Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>59th Medical Wing</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>59th Medical Wing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Photorefractive keratectomy (PRK) is a refractive error correction procedure that helps&#xD;
      eliminate or reduce the dependence on corrective lenses. An important aspect of PRK is&#xD;
      post-operative pain management. Post-operative pain can be significant in the first three to&#xD;
      five days and is typically controlled utilizing various modalities including narcotic pain&#xD;
      medication. Simple observation suggests a difference in the post-operative pain levels of&#xD;
      patients utilizing the more potent oxycodone- versus the less potent codeine-containing&#xD;
      acetaminophen preparations. There have been no studies performed to explore any differences&#xD;
      in perceived pain comparing these two medications when used following PRK. This study is&#xD;
      designed to answer this question by means of a pain survey conducted in the first five days&#xD;
      post-op. This may help better manage similar patients in the future.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective pain assessment study utilizing a simple three question survey&#xD;
      given to patients undergoing bilateral PRK. Following recruitment and enrollment (see section&#xD;
      4.1 and 4.2 for recruitment and consent process), patients will be randomized to be&#xD;
      prescribed either 1) Group 1: codeine 30mg/acetaminophen 300mg (standard of care dosage) or&#xD;
      2) Group 2: oxycodone 5mg/acetaminophen 325mg (standard of care dosage) post-operatively. All&#xD;
      post-operative patients will receive standard bandage contact lenses and as needed tetracaine&#xD;
      as per standard of care. Patients will be removed from the study if they take other non-study&#xD;
      pain medications. They will be asked to record their pain levels four times daily as well as&#xD;
      the number of as needed narcotic pain medication taken and the number of tetracaine drops&#xD;
      used (to isolate a potential confounding pain control modality). Randomization will be&#xD;
      performed with the aid of www.randomizer.org which will generate a randomized assignment to&#xD;
      either group 1 or group 2.&#xD;
&#xD;
      All PRK procedures will be performed per standard of care. The procedure will be performed by&#xD;
      one of the 4 approved surgeons. All surgeons will use the same technique using either the&#xD;
      VISX or the Allegretto laser machines. This technique will include use of a brush for&#xD;
      mechanical removal of corneal epithelial cells. The surgeons will take note at this time of&#xD;
      the relative adherence of the epithelium to the underlying tissue and grade the adherence on&#xD;
      a scale of 0-4 (0=least adherent and 4=most adherent). In the data analysis, differences&#xD;
      between surgeons and between operating platform (VISX vs Allegretto) will be compared to&#xD;
      account for any possible bias in operating parameters.&#xD;
&#xD;
      The survey will be worded as follows:&#xD;
&#xD;
        1. &quot;Rate your eye pain or level of discomfort at 0800, 1200, 1600 and 2000. Please write&#xD;
           the number closest to your response in the table below under the appropriate day and&#xD;
           time.&#xD;
&#xD;
        2. &quot;How many tablets of study-related pain medication did you take today in the AM/PM?&quot;&#xD;
&#xD;
        3. &quot;How many times did you use topical tetracaine today in the AM/PM?&quot;&#xD;
&#xD;
        4. &quot;Did you take any other non-study related pain medications?&quot;&#xD;
&#xD;
      Patients will be followed-up post-operatively as per standard of care. This includes&#xD;
      follow-up visits at 1 day, 1 week, 1 month, 3 months, 6 months and 12 months. Starting on&#xD;
      post-operative day 1, the patients will be asked to record their pain levels using the pain&#xD;
      survey at four hour intervals (0800, 1200, 1600, 2000). At the 1 week post-operative visit,&#xD;
      the pain surveys will be collected from the patients. Visual acuity data will be extracted&#xD;
      from all but the 12 month follow-up appointment and used as a secondary outcome to correlate&#xD;
      any possible differences in pain scores to functional outcomes in terms of visual acuity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 21, 2017</start_date>
  <completion_date type="Actual">October 28, 2019</completion_date>
  <primary_completion_date type="Actual">October 28, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to Group 1 or Group 2</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Randomization was accomplished by the pharmacy and the medication bottles were not labeled.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative Average Pain Score</measure>
    <time_frame>2 days post surgery</time_frame>
    <description>The PRK Post-Operative Pain Survey consisted of a scale of 0 - 10 with a score of 0 equal to no pain, a score of 1 - 3 equal to mild pain, a score of 4 - 6 equal to moderate pain and a score of 7 - 10 equal to severe pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative Uncorrected Visual Acuity Right and Left Eye</measure>
    <time_frame>Post-operative month 6.</time_frame>
    <description>Right and left eye uncorrected visual acuity at post-operative month 6.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Post-operative Pain Control</condition>
  <arm_group>
    <arm_group_label>Acetaminophen with codeine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen with oxycodone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetaminophen/codeine vs acetaminophen/oxycodone</intervention_name>
    <description>pain medications</description>
    <arm_group_label>Acetaminophen with codeine</arm_group_label>
    <arm_group_label>Acetaminophen with oxycodone</arm_group_label>
    <other_name>Tylenol 3 VS Percocet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  M/F &gt;21 years of age (PRK is not done on anyone under the age of 21 at this surgery&#xD;
             center)&#xD;
&#xD;
          -  Have met all criteria for bilateral PRK&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Patients who do not meet the criteria for refractive surgery&#xD;
&#xD;
          -  Patients receiving LASIK&#xD;
&#xD;
          -  Patients known to have an allergy to either of the study pain medications&#xD;
&#xD;
          -  Patients receiving refractive surgery on only one eye&#xD;
&#xD;
          -  Pregnant women, children, military basic trainees, prisoners and detainees&#xD;
&#xD;
          -  Subject has used narcotics in the last 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charisma B Evangelista, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>59th Medical Wing</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Joint Warfighter Refractive Surgery Center at WHASC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2020</study_first_posted>
  <results_first_submitted>July 21, 2021</results_first_submitted>
  <results_first_submitted_qc>September 8, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 5, 2021</results_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>59th Medical Wing</investigator_affiliation>
    <investigator_full_name>Charisma Evangelista</investigator_full_name>
    <investigator_title>Chief of Refractive Surgery</investigator_title>
  </responsible_party>
  <keyword>Photorefractive Keratectomy</keyword>
  <keyword>Post-operative Eye Pain</keyword>
  <keyword>Refractive Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/22/NCT04399122/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>In this single-center, double-masked randomized clinical trial, patients were recruited at the Joint Warfighter Refractive Surgery Center (JWRSC) at Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base, Texas, between March 2016 and April 2019.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Acetaminophen With Codeine</title>
          <description>codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
        </group>
        <group group_id="P2">
          <title>Acetaminophen With Oxycodone</title>
          <description>oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
                <participants group_id="P2" count="100"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
                <participants group_id="P2" count="100"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Three participants withdrew from the acetaminophen with codeine arm: One participant withdrew from the study because they did not wish to proceed with refractive surgery. Two participants withdrew due to their inability to return for all required follow-up visits.</population>
      <group_list>
        <group group_id="B1">
          <title>Acetaminophen With Codeine</title>
          <description>codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
        </group>
        <group group_id="B2">
          <title>Acetaminophen With Oxycodone</title>
          <description>oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="97"/>
            <count group_id="B2" value="100"/>
            <count group_id="B3" value="197"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="97"/>
                    <count group_id="B2" value="100"/>
                    <count group_id="B3" value="197"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="197"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="97"/>
                    <count group_id="B2" value="100"/>
                    <count group_id="B3" value="197"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.5" spread="7.5"/>
                    <measurement group_id="B2" value="31.5" spread="6.5"/>
                    <measurement group_id="B3" value="32.5" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="97"/>
                    <count group_id="B2" value="100"/>
                    <count group_id="B3" value="197"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="73"/>
                    <measurement group_id="B3" value="154"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="97"/>
                    <count group_id="B2" value="100"/>
                    <count group_id="B3" value="197"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post-operative Average Pain Score</title>
        <description>The PRK Post-Operative Pain Survey consisted of a scale of 0 - 10 with a score of 0 equal to no pain, a score of 1 - 3 equal to mild pain, a score of 4 - 6 equal to moderate pain and a score of 7 - 10 equal to severe pain</description>
        <time_frame>2 days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen With Codeine</title>
            <description>codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen With Oxycodone</title>
            <description>oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Average Pain Score</title>
          <description>The PRK Post-Operative Pain Survey consisted of a scale of 0 - 10 with a score of 0 equal to no pain, a score of 1 - 3 equal to mild pain, a score of 4 - 6 equal to moderate pain and a score of 7 - 10 equal to severe pain</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.82" spread="2.03"/>
                    <measurement group_id="O2" value="3.58" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative Uncorrected Visual Acuity Right and Left Eye</title>
        <description>Right and left eye uncorrected visual acuity at post-operative month 6.</description>
        <time_frame>Post-operative month 6.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen With Codeine</title>
            <description>codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
          </group>
          <group group_id="O2">
            <title>Acetaminophen With Oxycodone</title>
            <description>oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Uncorrected Visual Acuity Right and Left Eye</title>
          <description>Right and left eye uncorrected visual acuity at post-operative month 6.</description>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right Eye logMAR</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.01"/>
                    <measurement group_id="O2" value="-0.05" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Eye logMAR</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.01"/>
                    <measurement group_id="O2" value="-0.06" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acetaminophen With Codeine</title>
          <description>codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
        </group>
        <group group_id="E2">
          <title>Acetaminophen With Oxycodone</title>
          <description>oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.&#xD;
acetaminophen/codeine vs acetaminophen/oxycodone: pain medications</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jose E. Capo-Aponte</name_or_title>
      <organization>Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center</organization>
      <phone>(210) 292-2554</phone>
      <email>Jose.E.CapoAponte.ctr@mail.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

